Daniel W. Bowles

Also affiliated with University of Colorado Anschutz Medical Campus, University of Colorado Denver

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 16 papers. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study

The Lancet Diabetes & Endocrinology(2021)10.1016/s2213-8587(21)00120-0

N/A

5.1DataRank · unranked

354 citations

Mimi I. Hu, Lori J. Wirth, Martin Schüler, Aaron S. Mansfield, Giuseppe Curigliano +20 more

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

Nature Medicine(2022)10.1038/s41591-022-01931-y

N/A

3.9DataRank · unranked

240 citations

Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz‐Ares, Pilar Garrido +14 more

A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC

Nature Cancer(2022)10.1038/s43018-022-00450-6

N/A

2.7DataRank · unranked

93 citations

Michael W. Knitz, Junxiao Hu, Eric T. Clambey, Jennifer Backus, Andrew Dumit +29 more

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

JAMA Oncology(2022)10.1001/jamaoncol.2022.5357

N/A

1.5DataRank · unranked

63 citations

Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih–Yuan Hsu +95 more

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Annals of Oncology(2022)10.1016/j.annonc.2022.08.002

N/A

0.782DataRank · unranked

183 citations

Giuseppe Curigliano, Michael Thomas, Vivek Subbiah, Christina S. Baik, Daniel S.W. Tan +21 more

The intersection between cannabis and cancer in the United States

Critical Reviews in Oncology/Hematology(2012)10.1016/j.critrevonc.2011.09.008

N/A

0.631DataRank · unranked

66 citations

Cindy L. O’Bryant, D. Ross Camidge, Antonio Jimeno, Daniel W. Bowles

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0.529DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1030

N/A

0.494DataRank · unranked

26 citations

Myung‐Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W. Bowles, Deborah J. Wong +9 more

Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin

UNC Libraries(2020)10.17615/4xwv-h732

N/A

0.189DataRank · unranked

1 citations

Cindy L. O’Bryant, Madeleine Gomez, Melanie S. Joy, Susan L. Hogan, Daniel W. Bowles +6 more

Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC

Nature Cancer(2024)10.1038/s43018-024-00724-1

N/A

0.104DataRank · unranked

1 citations

Michael W. Knitz, Junxiao Hu, Eric T. Clambey, Jennifer Backus, Andrew Dumit +30 more

Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC

Nature Cancer(2022)10.1038/s43018-022-00507-6

N/A

0.104DataRank · unranked

1 citations

Michael W. Knitz, Junxiao Hu, Eric T. Clambey, Jennifer Backus, Andrew Dumit +30 more

Time-dependent changes in kidney injury biomarkers in patients receiving multiple cycles of cisplatin chemotherapy

Toxicology Reports(2020)10.1016/j.toxrep.2020.04.003

N/A

0DataRank · unranked

31 citations

Wen Xia, Nickie Mercke, Madeleine Gomez, Cindy L. O’Bryant, Daniel W. Bowles +5 more

Population Pharmacokinetic Model of Platinum Disposition in Cancer Patients Receiving Cisplatin and Randomized to 5‐HT3 Antagonist Antiemetic Drugs

The Journal of Clinical Pharmacology(2024)10.1002/jcph.6177

N/A

0DataRank · unranked

2 citations

Anukul Ghimire, Wen Xia, Christine Kim, Cathleen Doherty, Brian Buckley +6 more

Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.10.147

N/A

0DataRank · unranked

67 citations

Richard Castillo, Edward Castillo, Leah Schubert, Bernard L. Jones, Austin M. Faught +13 more